Beyond Air (XAIR) Cash from Investing Activities (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,783.75% |
| Sep 30, 2025 | -58.33% |
| Jun 30, 2025 | -77.68% |
| Mar 31, 2025 | 137.21% |
| Dec 31, 2024 | -142.96% |
| Sep 30, 2024 | 418.50% |
| Jun 30, 2024 | 286.80% |
| Mar 31, 2024 | -295.43% |
| Dec 31, 2023 | 148.25% |
| Sep 30, 2023 | 81.68% |
| Jun 30, 2023 | -208.95% |
| Mar 31, 2023 | 101.91% |
| Dec 31, 2022 | 113.07% |
| Sep 30, 2022 | -12,616.29% |
| Jun 30, 2022 | 22.12% |
| Mar 31, 2022 | 19.09% |
| Dec 31, 2021 | 36.99% |
| Sep 30, 2021 | -2,362.96% |
| Jun 30, 2021 | -35.00% |
| Mar 31, 2021 | 85.61% |
| Dec 31, 2020 | 71.49% |
| Sep 30, 2020 | -100.17% |
| Jun 30, 2020 | -101.95% |
| Mar 31, 2020 | 353.75% |
| Dec 31, 2019 | -234.53% |
| Sep 30, 2019 | 153.87% |
| Jun 30, 2019 | 6.84% |
| Mar 31, 2019 | -513.22% |
| Dec 31, 2018 | 0.47% |
| Sep 30, 2018 | -10.95% |
| Jun 30, 2018 | 125.53% |
| Mar 31, 2018 | -836.02% |
| Dec 31, 2017 | 59.59% |
| Sep 30, 2017 | -4,328.26% |
| Jun 30, 2017 | 85.63% |
| Mar 31, 2017 | -3,009.71% |
| Dec 31, 2016 | 266.67% |